MiRNA expression patterns are associated with tumor mutational burden in lung adenocarcinoma

Background: Tumor mutational burden (TMB) has emerged as an independent biomarker to predict patient responses to treatment with immune checkpoint inhibitors (ICIs) for lung adenocarcinoma (LUAD). MicroRNAs (miRNAs) have a crucial role in the regulation of anticancer immune responses, but the associ...

Full description

Bibliographic Details
Main Authors: Yufeng Lv, Zhong Huang, Yan Lin, Yuan Fang, Zhichao Chen, Lili Pan, Yanxian Zhang, Zihai Xu
Format: Article
Language:English
Published: Taylor & Francis Group 2019-10-01
Series:OncoImmunology
Subjects:
Online Access:http://dx.doi.org/10.1080/2162402X.2019.1629260

Similar Items